Trials / Completed
CompletedNCT05416814
Safety and Feasibility of Kefir Administration in Critically Ill Adults
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and feasibility of kefir administration in critically ill adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Kefir | Oral route (via feeding tube in intubated patients). Serving size 240mL to be given in an ascending dosing regimen if tolerated starting at 60 mL/day, 120 mL/day until single 240 mL/day; if evidence of intolerance, dose will be reduced to previously tolerated dose. |
Timeline
- Start date
- 2022-07-12
- Primary completion
- 2023-02-04
- Completion
- 2023-12-03
- First posted
- 2022-06-13
- Last updated
- 2023-12-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05416814. Inclusion in this directory is not an endorsement.